Tsukahara, Ryoko
61  Ergebnisse:
Personensuche X
?
1

Secreted PLA2-III is a possible therapeutic target to treat..:

Tanaka, Keigo ; Dozono, Naoki ; Neyama, Hiroyuki...
Biochemical and Biophysical Research Communications.  568 (2021)  - p. 167-173 , 2021
 
?
3

Evaluation of the pharmacokinetics of 2-carba-cyclic phosph..:

Shimizu, Yoshibumi ; Fukasawa, Keiko ; Yamamoto, Shinji...
Prostaglandins & Other Lipid Mediators.  150 (2020)  - p. 106450 , 2020
 
?
 
?
 
?
7

Myelin-related gene silencing mediated by LPA1 – Rho/ROCK s..:

Tsukahara, Ryoko ; Ueda, Hiroshi
Journal of Pharmacological Sciences.  132 (2016)  2 - p. 162-165 , 2016
 
?
8

Cyclic phosphatidic acid inhibits the secretion of vascular..:

Tsukahara, Tamotsu ; Tsukahara, Ryoko ; Haniu, Hisao..
Molecular and Cellular Endocrinology.  412 (2015)  - p. 320-329 , 2015
 
?
 
?
12

2D binary QSAR modeling of LPA3 receptor antagonism:

Fells, James I. ; Tsukahara, Ryoko ; Liu, Jianxiong..
Journal of Molecular Graphics and Modelling.  28 (2010)  8 - p. 828-833 , 2010
 
?
14

Lysophosphatidic Acid 2 Receptor-mediated Supramolecular Co..:

E, Shuyu ; Lai, Yun-Ju ; Tsukahara, Ryoko...
Journal of Biological Chemistry.  284 (2009)  21 - p. 14558-14571 , 2009
 
?
15

Structure-based drug design identifies novel LPA3 antagonis..:

Fells, James I. ; Tsukahara, Ryoko ; Liu, Jianxiong..
Bioorganic & Medicinal Chemistry.  17 (2009)  21 - p. 7457-7464 , 2009
 
1-15